Authors


Katie Eder, Senior Editor

Latest:

7 OTC Product Categories Completely Covered by Insurance

Did you know that health plans completely cover certain OTC products when patients present a prescription?


Jennifer N. Clements, PharmD, BCPS, CDE

Latest:

Lipid Management When Converting Fluvastatin to Pravastatin: Medication Use Evaluation

There were no signifi cant differences in mean low-density lipoprotein cholesterol levels after patients were converted from fl uvastatin to pravastatin therapy.


Millie Mo, PharmD, BCPS

Latest:

Precision Medicine and the Pharmacist’s Role as a Trusted Counselor in Specialty Pharmacy

The placement of clinical pharmacists at the nexus of functional pharmacogenomics and in specialty pharmacy care makes good sense.


Keith Overfield

Latest:

Long-Term Care: Expanding Into the Market

Demonstrating success is critical to building a long-term care business. How can your pharmacy make a difference?


Edna Bowser, CPhT

Latest:

Joining a Pharmacy Organization Yields Benefits

Gaining the most value from membership requires active participation by techs and a willingness to go outside their comfort zones.



Anthony Palmieri, PharmD, MBA

Latest:

The Impact of Abuse Deterrent Technologies on Prescription Opioid Trends

The authors examined trends in the utilization of prescription opioid medication following introduction of abuse deterrent technology for Oxycontin.


Marcy T. Holler, PharmD, CPP, BCPS

Latest:

Treatment of Microalbuminuria in Patients with Type 2 Diabetes in the Absence of Hypertension

In some circumstances, antihypertensives can play a role in treatment even when a patient's blood pressure readings are normal.


Anthony Mazzarese, PharmD, MSPBA

Latest:

Will Specialty Pharmacies Be Needed in the Future?

Drug development and innovation could render the current specialty pharmacy model obsolete in 20 years.


R. Scott Leslie, MPH

Latest:

Patient Characteristics and Medication Burden Affect Adherence Among Seniors

Adherence among seniors to 3 widely used chronic medication classes differed by medication burden, patient characteristics, and specific comorbid conditions.


Les Paul, MD, MS

Latest:

Healthcare Reform, Comparative Effectiveness Research, and P&T Decisions

The conduct and interpretation of comparative effectiveness research must build confidence that this research will enable improved access to appropriate healthcare interventions.


Jenine Abuzir, PharmD Candidate

Latest:

The Value of Student Teachers in Pharmacy School

There is no greater support team available to students than their pharmacy school.


Rena Bielinski, PharmD, AHFI

Latest:

Behavioral Analytics: Key to Shutting Down the Medicare Part D ATM

Advanced behavioral analytics can differentiate patterns of fraud and abuse from instances such as oncology patients receiving multiple prescriptions from different specialists.



Maria R. Baer, MD

Latest:

Utilization Impacts of New Oral Substitutes for Parenteral Cancer-Related Therapies

Examination of changes in utilization, dose adequacy, and duration associated with market entry of the oral chelator deferasirox as a potential substitute for parenteral deferoxamine.


Harold Laudien

Latest:

HEALTH SAVINGS ACCOUNTS: AN ANSWER TO RISING HEALTH CARE COSTS

Mr. Laudien is a financial advisor with Merrill Lynch in Princeton, NJ, member of Securities Investor Protection Corp.


Marile L. Santamarina, MS, PharmD, CPh

Latest:

Prescription Drug Adherence: A "Challenge" for So Many…

Poor medication compliance in chronic diseases in a well-known public health problem. Pharmacists play a key role in optimizing medication use in patients with chronic conditions.





Andrew Merker, PharmD

Latest:

HIV Infection: The Future of Therapy

Approximately 35 million individuals are currently living with HIV/AIDS.


G. Caleb Alexander, MD, FACP

Latest:

Impact of HIE Drug Formularies on Patient Out-of-Pocket Costs

Benefit structure and formulary design characteristics are important for individuals with high out-of-pocket costs in federally facilitated Health Insurance Exchanges.


Jim Jorgenson, RPh, MS

Latest:

Staging Colon Cancer: New Directions and Managed Care Implications

In September 2009, the Pharmacy & Therapeutics Society gathered a study group of 12 managed care medical and pharmacy directors. The objective was to examine the impact that biomarker-based assays could have on the approaches payers and providers use to manage cancer.


Marile L. Santamarina, PharmD, MS

Latest:

Diabetes and Depression: Knowing the Signs, Improving Outcomes

Pharmacists should encourage patients to recognize and report any symptoms of depression in order to achieve optimal control of diabetes.


Julio Vazquez, MS, PharmD

Latest:

Daily Dose and Costs of Therapy With Topical Testosterone Agents

We assessed time to maintenance dose attainment in commercially insured men initiating topical testosterone agents and compared daily maintenance doses and costs of this therapy.


Davy James

Latest:

Novel Drug Treats Allergic Asthma Without Inhibiting Flu Defenses

Inhibiting the calcium release-activated calcium channel found to be an effective approach to limit allergic asthma without affecting the body’s defenses against influenza.


Jeffery Fudin, PHARMD, DAIPM, FCCP, FASHP, FFSMB

Latest:

Carefully Assess Opioid Drug Interaction Risks

A CMS guide to the new medicare part D overutilization policies has takeaways for pharmacists.


Denise Swiatek, BS, PharmD

Latest:

Not Just Dispensing: The Unique Role of Pharmacists in an Outpatient Research Pharmacy

Pharmacists can serve as essential members of a research team in a role that involves much more than traditional dispensing functions.


Canyon Hopkins, PharmD Candidate

Latest:

Acute Coronary Syndrome Is a Medical Emergency

Pharmacists should identify barriers that may prevent patients from adhering to complicated regimens or receiving proper care.